We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Wearable Rapid Gas Analyzer Could Detect Illness Immediately

By LabMedica International staff writers
Posted on 08 Aug 2022

Advancements in micro-gas chromatography in the past 20 years have demonstrated great potential for the development of powerful portable gas analysis devices. More...

But it remains a challenge to achieve efficient separation and rapid detection for effective gas analysis in a highly integrated and cost-effective platform, as well as in a mobile device. Now, researchers are creating a portable, wearable device for rapid gas analysis that could detect illness immediately.

The device being created by electrical engineering researchers at The University of Texas at Arlington (Arlington, TX, USA) will play an important role in health care, among other sectors. The project will create technology to transform a powerful gas analysis instrument traditionally used in research labs into portable and wearable devices that are easily accepted and accessible by the public. The project has received a USD 550,000 National Science Foundation (NSF) grant from the Partnerships for Innovation–Research Partnerships program, which aims to take devices developed in the laboratory to the marketplace more quickly.

The vast applications could propel the device to the marketplace more quickly. In health care, the device could analyze a person’s breath samples to find chemical markers that are specifically linked to infections, cancers and other health conditions. In turn, that could lead to a convenient and rapid health screening and monitoring tool to be used at home.

“The key to the project is system-level integration, including creating new micro-gas chromatography architecture and using photonic integrated circuits to achieve rapid and comprehensive volatile organic compounds gas analysis,” said Yuze “Alice” Sun, an associate professor in the Department of Electrical Engineering, who is the principal investigator on the project.

“Not only does the project have the potential of improving our lives, but it could take up so much less space than current chromatography analysis machines,” said Diane Huffaker, chair and professor of electrical engineering. “This could save an enormous amount of testing time, too.”

Related Links:
The University of Texas at Arlington 


New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Clinical Informatics Platform
CLARION™
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.